Advertisement

Topics

Yoshitomi Pharmaceutical Industries Limited Company Profile

20:36 EST 15th December 2018 | BioPortfolio

Anti-Bacterial

Location

6-7Yushima 1-chome Bunkyo-ku
Tokyo
Tokyo
113
Japan

Contact

Phone: 81 3 5802 0600
Fax: 81 3 5802 0609


News Articles [616 Associated News Articles listed on BioPortfolio]

Veritas Announces Binding Share Purchase Agreement with Leis Industries Limited for Sale of Sechelt Organic Marijuana

VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has...

Kal Sundaram appointed as chairman of Taro Pharmaceutical

Taro Pharmaceutical Industries Ltd. (Taro) announced that Dilip Shanghvi has resigned, effective April 18, as chairman and a member of Taro's board of directors in order to focus on other growth prior...

TEVA Pharmaceutical Industries: Die Käufer sind bemüht, aber …

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus sie bis zum 12. Januar wieder kontinuierlich bis auf 22,64 US-Do...

TEVA Pharmaceutical Industries: Ein empfindlicher Rücksetzer

Am 2. November erreichte die Aktie des Generkia-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich bis auf 22,64 ...

TEVA Pharmaceutical Industries: Auf einem guten Weg!

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich anstieg. Das b...

TEVA Pharmaceutical Industries: Gegenwind für die Käufer!

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich anstieg. Das b...

TEVA Pharmaceutical Industries: Es wird eng für die Käufer!

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich anstieg. Das b...

TEVA Pharmaceutical Industries: Die Anleger verkaufen die guten Zahlen!

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich bis auf 22,64 ...

PubMed Articles [617 Associated PubMed Articles listed on BioPortfolio]

Analysis of Pin Milling of Pharmaceutical Materials.

Milling is an important process for tailoring the particle size distribution for enhanced dissolution, content uniformity, tableting, etc., specially for active pharmaceutical ingredients and excipien...

A network analysis of indirect carbon emission flows among different industries in China.

Indirect carbon emissions account for a large ratio of the total carbon emissions in processes to make the final products, and this implies indirect carbon emission flow across industries. Understandi...

Industry Payments in Cardiology: A Cross-sectional Analysis of Open Payments Data.

The goal of Open Payments and the Physician Payments Sunshine Act is to foster transparency and accountability to help stakeholders better understand financial ties between physicians and teaching hos...

Complex coacervation: Principles, mechanisms and applications in microencapsulation.

Complex coacervation is a highly promising microencapsulation technique that is extensively employed in pharmaceutical, food, agriculture and textile industries. The process involves the interaction o...

Microfluidics contribution to pharmaceutical sciences: From drug discovery to post marketing product management.

Drug discovery and development is a long-lasting process in which many challenges have to be addressed at every stage, from the discovery of the target biomolecule to the commercialization of the disc...

Clinical Trials [351 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Lansoprazole 30 mg DR Capsule Fasting Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by ...

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

The study will compare the relative bioavailability (rate and extent of absorption) of 200 mg/5 mL Azithromycin oral suspension manufactured by TEVA Pharmaceutical Industries Ltd.; distrib...

Companies [2301 Associated Companies listed on BioPortfolio]

Yoshitomi Pharmaceutical Industries Limited

Anti-Bacterial

AARTI INDUSTRIES LIMITED

The first unit of AARTI group, ALCHEMIE LABORATORIES, commenced commercial production of DIMETHYL SULPHATE (DMS) in the year 1975. Today, AARTI has acquired world-class expertise in the development an...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

BARAKAT Pharmaceutical Industries

BARAKAT Pharmaceutical Industries is one of the leading-well established and most inveterate Syrian private companies specializing in the production of human medicines. The Company was founded in 1972...

EFPIA (The European Federation of Pharmaceutical Industries and Associations)

EFPIA (The European Federation of Pharmaceutical Industries and Associations) represents the research-based pharmaceutical industry operating in Europe.Through its direct membership of 28 national pha...

More Information about "Yoshitomi Pharmaceutical Industries Limited" on BioPortfolio

We have published hundreds of Yoshitomi Pharmaceutical Industries Limited news stories on BioPortfolio along with dozens of Yoshitomi Pharmaceutical Industries Limited Clinical Trials and PubMed Articles about Yoshitomi Pharmaceutical Industries Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Yoshitomi Pharmaceutical Industries Limited Companies in our database. You can also find out about relevant Yoshitomi Pharmaceutical Industries Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record